Sleep Optimization Stack: Evidence and Comparison

What does this guide compare?

This comparison includes melatonin, whose circadian role differs from the other ingredients.

This collection compares products discussed around one topic. It is not a protocol to take in full. Links to individual profiles appear after the article.

Which products are compared?

Magnesium, L-Theanine, Apigenin, Melatonin.

Individual profiles describe formulation, source-reported amounts, tolerability and interactions. Those details remain ingredient-specific. An amount studied alone is not automatically appropriate in a combination.

How do their roles differ?

Melatonin signals biological night and has a timing-dependent circadian role. Magnesium participates in neuronal and metabolic processes, while theanine, apigenin and inositol are discussed for different proposed calming effects. They are not interchangeable, and their presence together does not establish a deeper-sleep protocol. [1][2][3]

What does the research show?

A 2025 placebo-controlled trial in 155 adults with poor sleep studied magnesium bisglycinate for four weeks. The improvement in insomnia scores was modest (between-group effect size d = 0.2) and based on self-report. It does not demonstrate an increase in deep-sleep stages, long-term benefit or efficacy of the full collection. Melatonin evidence is more specific to circadian problems; chronic insomnia guidelines prioritize cognitive behavioral therapy for insomnia. [1][2][3]

An observational association, a laboratory finding and a perceived benefit answer different questions. Randomized trials need their comparator, duration and population kept in view. An inconclusive result does not establish that an effect is impossible; it limits the claim that can be made.

L-theanine and perceived sleep

A 2025 synthesis identified 19 articles and 897 participants, with 18 articles pooled. Findings favored theanine for subjective sleep-onset latency (standardized mean difference 0.15), daytime dysfunction (0.33) and overall subjective sleep quality (0.43). These are standardized effects, not minutes of extra sleep. Few studies tested pure theanine, and preparations varied, limiting attribution to theanine alone and preventing a settled dose or duration. The review does not validate this entire combination. [6]

Which overlaps and risks matter?

Cautions and interactions

Combining sedating products, alcohol or sedative medicines can complicate next-day functioning. Magnesium may cause digestive effects; kidney disease changes safety. Persistent insomnia, breathing pauses and substantial daytime sleepiness warrant evaluation rather than escalating a stack. [1][2][3]

A complete product list includes prescription medicines, nonprescription products and supplements. Combination formulas can conceal duplicate ingredients. Timing and spacing from a medicine should follow its labeling and pharmacist guidance; this collection does not supply a universal timetable.

Regulatory status

In the United States, FDA does not approve dietary supplements for safety and effectiveness before marketing. In Canada, a natural health product requires a product licence before sale; its NPN or DIN-HM must match the finished product. An ingredient name or inclusion in this collection does not establish that every product or claim is authorized. Authorization also does not validate the complete combination. [4], [5]

Melatonin in Canada. Since June 2, 2026, melatonin sold for any sleep-related use in children and adolescents under 18 falls within prescription-drug scheduling. This change does not affect already licensed adult natural health products. Scheduling does not authorize every pediatric indication; the prescribed product’s specific indication still matters. [7]

What should be recorded and how should changes be interpreted?

Doserly brings dose logs, symptoms and routine changes together. For this collection, useful observations include bedtime, time to fall asleep, awakenings, next-day alertness, caffeine timing and each product change.

• Doses and adherence: record the formulation, amount actually taken, timing and missed doses so observations have context.
• Potential benefits and tolerability: compare consistent symptoms or measurements over time alongside sleep, food and activity changes. Personal trends help evaluate the experience without proving causal efficacy.
• Product list: maintain the full product list for review with a pharmacist or clinician.
• AI monthly reports: summarize recorded doses, symptoms and trends to prepare for a discussion. Reports depend on the data entered and are not a diagnosis or an instruction to change treatment.

Explore the topic further

Common questions

Did the magnesium trial demonstrate more deep sleep?

No. The cited four-week trial measured insomnia symptoms. A modest change in that score is not a direct measurement of deep-sleep architecture or a cure for insomnia. [2]

Does the trial establish a magnesium-only effect?

The specified bisglycinate preparation also provided glycine. Keep the product composition and comparator in view rather than transferring the result to every magnesium salt or combination. [2]

Does adding all the listed sleep products improve the chance of success?

The cited trial did not test the entire collection. Several changes at once can make benefit, daytime sedation and adverse effects harder to attribute. Record the product, timing, sleep pattern and daytime function. [1][2][3]

Is the sleep effect established for theanine alone?

The 2025 review found favorable signals on some subjective outcomes but too few pure-theanine studies. It establishes neither an insomnia treatment nor a universal schedule. [6]

Glossary

Terms for interpreting the comparisons.

Formulation

The exact preparation, including its ingredients, their forms and labeled amounts.

Study population

The people included in a study; their characteristics limit where its result applies.

Comparator

The placebo, treatment or condition used as the comparison.

Measured outcome

What the study evaluates, such as a symptom, laboratory result or clinical event.

Overlap

The same ingredient appearing in more than one product used together.

How was this guide researched?

Sources and limits

This AI-assisted educational guide compares the cited public references. Findings remain tied to the ingredients, preparations and populations studied. It is not a systematic review or independent medical peer review. Doserly develops a commercial tracking app. Illustrations explain concepts; app screens show example data. Report a correction with its source to Doserly support.

Explore the sources